#Research #COVID19 #Liver
#CUHK School of Medicine: 20% of COVID-19 patients have liver damage, and the risk of deterioration and death is 8 times more
Read more
⬇️⬇️⬇️⬇️
https://t.me/guardiansofhongkong/24013
#CUHK School of Medicine: 20% of COVID-19 patients have liver damage, and the risk of deterioration and death is 8 times more
Read more
⬇️⬇️⬇️⬇️
https://t.me/guardiansofhongkong/24013
#Research #COVID19 #Liver
#CUHK School of Medicine: 20% of COVID-19 patients have liver damage, and the risk of deterioration and death is 8 times more
The study was conducted by the School of Medicine of the Hong Kong Chinese University (CUHK).The sameple covered 1,040 COVID19 patients in Honv Kong diagnosed from January 23 to May 1 this year, with a median age of 35 years.
The research team collected liver function indexes from these patients during their hospitalization and found that 22.5% (234 people) had liver damage. In the sample, 5.1% (53 people) had been in the intensive care unit, and 2.1% (22 people) had needed equipment to assist breathing. Another 0.4% (4 people) died, of which 71% were patients with liver damage.
Professor Wong Lai-hung, specializing in Gastroenterology and Hepatology at the Department of Internal Medicine and Drug Therapy of CUHK, said that the patient’s liver function is impaired, which may be caused by the inflammation caused by COVID-19, excessive blood pressure and oxygen content, or the effect of drugs used in treatment, as patients treated with more types of drugs are 90% more likely to have liver function problems than other patients.This means that patients who have to take multiple drugs due to a more severe pneumonia are at higher risk.
Prof. Wong suggested that the liver function of patients should be monitored so that any illness can be detected at an early stage.
Source: InMedia #Aug5
#CUHK School of Medicine: 20% of COVID-19 patients have liver damage, and the risk of deterioration and death is 8 times more
The study was conducted by the School of Medicine of the Hong Kong Chinese University (CUHK).The sameple covered 1,040 COVID19 patients in Honv Kong diagnosed from January 23 to May 1 this year, with a median age of 35 years.
The research team collected liver function indexes from these patients during their hospitalization and found that 22.5% (234 people) had liver damage. In the sample, 5.1% (53 people) had been in the intensive care unit, and 2.1% (22 people) had needed equipment to assist breathing. Another 0.4% (4 people) died, of which 71% were patients with liver damage.
Professor Wong Lai-hung, specializing in Gastroenterology and Hepatology at the Department of Internal Medicine and Drug Therapy of CUHK, said that the patient’s liver function is impaired, which may be caused by the inflammation caused by COVID-19, excessive blood pressure and oxygen content, or the effect of drugs used in treatment, as patients treated with more types of drugs are 90% more likely to have liver function problems than other patients.This means that patients who have to take multiple drugs due to a more severe pneumonia are at higher risk.
Prof. Wong suggested that the liver function of patients should be monitored so that any illness can be detected at an early stage.
Source: InMedia #Aug5